Skip to main content

Kestenberg-Messina Kaitlin M.'s Form 4 filing

Adma Biologics, Inc. (ADMA) · filed Mar 10, 2026

Accession no.
0001140361-26-008905
Filed
Mar 10, 2026
Trade date
Mar 6-9, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 5 derivative transactions. Open-market sales total $157.8K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kestenberg-Messina Kaitlin M.CIK 0002017423Officer (COO and SVP, Compliance)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 6, 2026Common StockFTax withholdingDisposed−10,059$15.39−$154,808.01562,101Direct
Mar 7, 2026Common StockFTax withholdingDisposed−4,235$15.39−$65,176.65557,866Direct
Mar 9, 2026Common StockJOtherDisposed−91,266$0.00$0466,600Direct
Mar 9, 2026Common StockMOption exerciseAcquired+2,500$5.00+$12,500469,100Direct
Mar 9, 2026Common StockMOption exerciseAcquired+1,250$4.31+$5,387.5470,350Direct
Mar 9, 2026Common StockMOption exerciseAcquired+2,646$2.83+$7,488.18472,996Direct
Mar 9, 2026Common StockMOption exerciseAcquired+1,525$2.35+$3,583.75474,521Direct
Mar 9, 2026Common StockMOption exerciseAcquired+2,175$1.55+$3,371.25476,696Direct
Mar 9, 2026Common StockSSaleDisposed−10,096$15.63−$157,800.48466,600Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 9, 2026Common StockMOption exerciseDisposed−2,500$0.00$02,500Direct
Mar 9, 2026Common StockMOption exerciseDisposed−1,250$0.00$01,250Direct
Mar 9, 2026Common StockMOption exerciseDisposed−2,646$0.00$02,771Direct
Mar 9, 2026Common StockMOption exerciseDisposed−1,525$0.00$02,225Direct
Mar 9, 2026Common StockMOption exerciseDisposed−2,175$0.00$02,825Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)